Form D · Biotechnology
MOLECULAR BIOMETRICS INC
Norwood, MA · CIK 0001448053
Offering snapshot reported Feb 4, 2010 · SEC filing
- Reported sold
- $12.8M Offering amount: $17M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $2 Reported outside-investor minimum
- First sale
- Dec 30, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 4, 2010 | Amendment | $12,755,376 | No comparison | 16 | SEC filing |
| Jan 11, 2010 | Initial | $12,500,000 | No comparison | 4 | SEC filing |
| Oct 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-123566
Source: Form D, filed Feb 4, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Barrett | Director |
| James Datin | Director |
| Edward Erickson | Director |
| Jonathan Fleming | Director |
| Thomas E Frank | Executive |
| Bruce Goldstein | Executive |
| James Posillico | Director, Executive |
| Robert Rochelle | Executive |
| Frank Thomas | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Suite 110, One Edgewater Drive
Norwood, MA, 02062
Norwood, MA, 02062